CCM2
Basic information
Region (hg38): 7:44999475-45076469
Previous symbols: [ "C7orf22" ]
Links
Phenotypes
GenCC
Source:
- cerebral cavernous malformation 2 (Strong), mode of inheritance: AD
- cerebral cavernous malformation 2 (Strong), mode of inheritance: AD
- famililal cerebral cavernous malformations (Supportive), mode of inheritance: AD
- cerebral cavernous malformation 2 (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cerebral cavernous malformations 2 | AD | Cardiovascular; Neurologic; Pharmacogenomic | Surveillance measures (eg, spinal cord MRI, annual brain gradient echo or susceptibility-weighted imaging) has been advocated; Agents that increase risk of hemorrhage should be avoided (eg, aspirin, NSAIDs, heparin, warfarin). | Cardiovascular; Neurologic | 14624391; 17211633; 17160895; 18060436; 18779516; 19088123; 21543988; 20301470 |
ClinVar
This is a list of variants' phenotypes submitted to
- Cerebral_cavernous_malformation_2 (210 variants)
- not_provided (96 variants)
- Inborn_genetic_diseases (88 variants)
- CCM2-related_disorder (20 variants)
- not_specified (18 variants)
- Cerebral_cavernous_malformation (4 variants)
- Vascular_dementia (2 variants)
- Vasculitis (1 variants)
- Cavernous_hemangioma (1 variants)
- Subcutaneous_venous_lacunae (1 variants)
- Cerebral_cavernous_angioma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCM2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000031443.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 59 | 64 | ||||
missense | 104 | 16 | 131 | |||
nonsense | 17 | 22 | ||||
start loss | 1 | 1 | 2 | |||
frameshift | 39 | 13 | 53 | |||
splice donor/acceptor (+/-2bp) | 12 | 21 | ||||
Total | 75 | 32 | 106 | 75 | 5 |
Highest pathogenic variant AF is 0.000025369
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCM2 | protein_coding | protein_coding | ENST00000381112 | 10 | 76995 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00928 | 0.989 | 125737 | 0 | 11 | 125748 | 0.0000437 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.518 | 244 | 268 | 0.911 | 0.0000177 | 3042 |
Missense in Polyphen | 74 | 107.67 | 0.68728 | 1166 | ||
Synonymous | -0.957 | 130 | 117 | 1.11 | 0.00000863 | 924 |
Loss of Function | 2.68 | 7 | 19.9 | 0.351 | 9.70e-7 | 243 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000444 | 0.0000439 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000163 | 0.000163 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the CCM signaling pathway which is a crucial regulator of heart and vessel formation and integrity. May act through the stabilization of endothelial cell junctions (By similarity). May function as a scaffold protein for MAP2K3-MAP3K3 signaling. Seems to play a major role in the modulation of MAP3K3- dependent p38 activation induced by hyperosmotic shock (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Cerebral cavernous malformations 2 (CCM2) [MIM:603284]: A congenital vascular anomaly of the central nervous system that can result in hemorrhagic stroke, seizures, recurrent headaches, and focal neurologic deficits. The lesions are characterized by grossly enlarged blood vessels consisting of a single layer of endothelium and without any intervening neural tissue, ranging in diameter from a few millimeters to several centimeters. {ECO:0000269|PubMed:14624391, ECO:0000269|PubMed:14740320, ECO:0000269|PubMed:22415356}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Regulation of p38-alpha and p38-beta;p38 MAPK signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.292
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 28.11
Haploinsufficiency Scores
- pHI
- 0.180
- hipred
- Y
- hipred_score
- 0.580
- ghis
- 0.527
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.700
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccm2
- Phenotype
- embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; immune system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- ccm2
- Affected structure
- blood vessel endothelial cell
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- vasculogenesis;in utero embryonic development;endothelial cell development;integrin-mediated signaling pathway;multicellular organism growth;cell-cell junction organization;inner ear development;venous blood vessel morphogenesis;stress-activated MAPK cascade;pericardium development;blood vessel endothelial cell differentiation;endothelial tube morphogenesis
- Cellular component
- cytoplasm;mitochondrion;protein-containing complex
- Molecular function
- protein binding